Psychopharmacology and Psychiatry Updates

247 Episodo

1. A Method for Tapering Antipsychotics

   Publicado: 8/12/2021
2. Management of Psychiatric Comorbidities With Alcohol Use Disorder

   Publicado: 3/12/2021
3. Tips for Treating Perimenopausal Depression

   Publicado: 28/11/2021
4. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

   Publicado: 23/11/2021
5. Subclinical Hypothyroidism in Depressed Adolescents

   Publicado: 18/11/2021
6. Principles for Managing Alcohol Use Disorder

   Publicado: 13/11/2021
7. ECT for Depressed Patients With Borderline Personality Disorder

   Publicado: 8/11/2021
8. Assessing and Treating Alcohol Withdrawal

   Publicado: 3/11/2021
9. Lab Tests in Psychopharmacology

   Publicado: 29/10/2021
10. Technology-Facilitated Adherence Enhancement and Family Involvement

    Publicado: 24/10/2021
11. Drug-Induced Hyperthermic Syndromes in Psychiatry

    Publicado: 19/10/2021
12. How to Improve Adherence: Targeting Reasons for Nonadherence

    Publicado: 14/10/2021
13. Esketamine: Postmarketing Safety Concerns

    Publicado: 9/10/2021
14. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Publicado: 4/10/2021
15. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicado: 29/9/2021
16. How to Assess Psychotropic Drug Adherence

    Publicado: 24/9/2021
17. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicado: 19/9/2021
18. Delirium, Catatonia, and COVID-19

    Publicado: 14/9/2021
19. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicado: 9/9/2021
20. Dopamine and Depression: Clinical Considerations

    Publicado: 4/9/2021